Related Experiment Videos
False positive results in cytotoxicity testing due to unexpectedly volatile compounds
G Ciapetti1, D Granchi, E Verri
1Laboratory for Biocompatibility Research on Implant Materials, Istituti Ortopedici Rizzoli, Bologna, Italy.
Journal of Biomedical Materials Research
|February 11, 1998
Summary
Dental material cytotoxicity testing requires careful sample preparation to prevent cross-contamination. Using multiple in vitro methods helps avoid false results in cell viability assays.
Area of Science:
- Biomaterials Science
- In Vitro Toxicology
- Dental Materials Research
Background:
- Cytotoxicity testing is crucial for screening new dental materials.
- Standard protocols like EN 30993 guide in vitro biological evaluations.
- Microplate assays are commonly used for cell viability assessments.
Purpose of the Study:
- To investigate the cytotoxicity of dental materials using established laboratory protocols.
- To evaluate the reliability of in vitro cytotoxicity assays, specifically neutral red and propidium iodide uptake.
- To identify potential sources of artifactual results in cytotoxicity screening.
Main Methods:
- Dental materials were extracted using aqueous solutions.
- Cell cultures were exposed to these extracts in microplates.
- Cell viability was assessed using neutral red uptake and propidium iodide uptake assays.
- Experimental conditions were analyzed to identify sources of discrepancies.
Main Results:
- Contrasting results were observed for one material between the two assay methods.
- A sustained release of volatile substances from one extract caused toxicity in adjacent cultures.
- This indicated cross-contamination within the microplate environment.
Conclusions:
- Sample distribution and potential for cross-contamination in microplates are critical factors in cytotoxicity testing.
- Employing multiple cytotoxicity assay methods is recommended to validate results and avoid false positives.
- Careful experimental design is necessary to prevent artifacts in in vitro dental material screening.